Holmes Joseph R.

Holmes Joseph R., Vice President & Chief Accounting Officer, has demonstrated a clear selling bias in his trading activity involving Thermo Fisher Scientific (TMO), the sole company in his transaction history. Over 32 reported trades, his total sales amount to $381,745.39, significantly outweighing his $97,786.15 in purchases. The most notable disposals occurred on August 29, 2025, when he sold shares worth $140,400.41 and $49,261.50, followed by an acquisition of shares valued at $97,786.15 the same day—likely tied to option exercises or planned transactions. More recently, on February 28, 2026, he executed four sales totaling $60,774.98, including transactions of $28,908.58 and $23,168.03, reinforcing the trend of reducing his position. Smaller, recurring sales appear throughout the data, such as multiple sub-$5,500 dispositions on August 28, 2025, and February 28, 2025, suggesting systematic divestment rather than isolated moves. While some filings show awards or adjustments (coded "A") with no reported value, the actionable transactions consistently lean toward liquidation. Holmes’s activity reflects a long-term pattern of monetizing his TMO holdings, with no recent buys offsetting the sales. The absence of diversification across other equities further underscores his concentrated exposure to Thermo Fisher and a persistent reduction in that stake over time.